3177 results for «397»
3177 results
Most impactful trials in structural heart disease 2024/2025
30 Sep 2025 – From PCR Gulf Valves 2025
Delve into the most impactful structural heart disease trials shaping 2024 and 2025. This session addresses current dilemmas in TAVI, including early intervention and management of small annuli, evaluates evidence for transcatheter mitral and tricuspid valve repair, and identifies evidence gaps relevant to the region, providing...
Second valve strategies with SAPIEN 3 Ultra RESILIA
30 Sep 2025 – From PCR Gulf Valves 2025
Gain key insights into managing second valve interventions with the SAPIEN 3 Ultra RESILIA system.
This session helps you anticipate and address complex scenarios such as mitral valve-in-valve, TAV-in-SAV, and valve-in-valve-in-valve procedures. Learn from expert case discussions that explore procedural strategies, technical challenges, and best practices to...
Abstracts and challenging clinical cases
30 Sep 2025 – From PCR Gulf Valves 2025
Engage with a dynamic collection of abstracts and challenging clinical cases that highlight the latest advances and investigative studies in interventional cardiology. Topics include innovative approaches to aortic stenosis management, AI-powered procedural planning, hemodynamic insights beyond traditional imaging, and complex valve interventions, providing a comprehensive overview...
3D echocardiography for structural procedures
30 Sep 2025 – From PCR Gulf Valves 2025
This session provides an in-depth understanding of three-dimensional (3D) echocardiography in structural heart procedures. Learn how to optimize 3D echocardiographic imaging for various valve interventions, including mitral valve procedures, and gain practical skills through hands-on training to enhance procedural guidance and outcomes.
Complex femoral access for TAVI in bicuspid aortic stenosis - LIVE Case
30 Sep 2025 – From PCR Gulf Valves 2025
A 74-year-old male with a history of multiple PCIs, peripheral arterial disease, and type 2 DM presented with symptomatic bicuspid aortic stenosis and preserved LV function.
A 26 mm Myval valve was implanted via right femoral artery access, with right radial secondary access, following predilatation with a...
Echocardiography for mitral valvuloplasty ballooning
30 Sep 2025 – From PCR Gulf Valves 2025
Enhance your expertise in echocardiography assessment and intraprocedural guidance for mitral valvuloplasty ballooning. This session focuses on evaluating mitral stenosis, distinguishing suitable from non-suitable candidates, and offers practical, hands-on experience to optimize procedural outcomes using echocardiographic techniques.
PCR Gulf Valves 2025 Closing Ceremony
30 Sep 2025 – From PCR Gulf Valves 2025
Join the PCR Gulf Valves 2025 Closing Ceremony to reflect on the advancements and highlights of this year’s sessions dedicated to valvular interventions. This event marks the culmination of comprehensive educational activities, fostering collaboration and innovation in valvular heart disease management within the Gulf region.
PCR Gulf Valves 2025 Opening Ceremony
29 Sep 2025 – From PCR Gulf Valves 2025
Join us for the PCR Gulf Valves 2025 Opening Ceremony, marking the commencement of an exceptional congress dedicated to advances in structural heart interventions. This session sets the stage for the latest innovations and expert discussions that will shape the future of valve therapies in the...
Left main bifurcation - LIVE Case
30 Jan 2026 – From SASCI-AfricaPCR
Join this session if you want to understand and optimise treatment strategies for LM bifurcation lesions, specifically: Understanding LM bifurcation anatomy and physiology, choosing the best stent strategy, optimising stent deployment and results.
LIVE Case from Groote Schuur Hospital Cape Town
Calcified lesions - LIVE Case
30 Jan 2026 – From SASCI-AfricaPCR
Watch this session if you want to understand the challenges and risks when treating calcified lesions, to learn how to accurately assess coronary calcification, to learn how to utilise the tools available for treating calcified lesions.
LIVE Case from Groote Schuur Hospital Cape Town
Design that delivers the future of TAVI
13 Feb 2026 – From PCR Tokyo Valves 2026
This session presents the future of TAVI valve design, emphasizing supra-annular valve benefits, strategies for managing concomitant coronary artery disease, and redo-TAVI approaches tailored for long-term patient management.
ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial
07 Nov 2022
Mirvat Alasnag provides her take on the ECMO-CS trial, which was presented during AHA 2022 in Chicago, and simultaneously published in Circulation.
Author
IMPELLA supported PCI via a single access sheath - Introduction and rapid adoption: the Power of Social Media
22 Dec 2020
This manuscript examines Impella single access technique, which provides a case example of the central role social media can play in the introduction of a new interventional approach.
RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation
05 Sep 2023
Alex Sticchi provides his take on the results of the RIVER trial, which were presented by Pedro Gabriel Barros E Silva during the ESC 2023 congress in Amsterdam.
Rivaroxaban versus Warfarin in Patients with Bioprosthetic Valves According to Valvular Heart Disease Etiology, and Thrombotic and Bleeding Risks: Insights from...
Author
The Lancet Commission to reduce global burden of cardiovascular disease in women by 2030
29 Aug 2021
Vijay Kunadian summarizes the key points of the LBT session of the ESC congress 2021 held on Sunday, 29 August focusing on the Lancet Commission to reduce the global burden of heart disease in women by 2030.
Author
The 2023 ESH Hypertension Guidelines revisit the role of renal denervation
05 Sep 2023
The 2023 European Society of Hypertension (ESH) guidelines were recently presented at the 32nd annual European Meeting on Hypertension and Cardiovascular Protection and simultaneously published in the Journal of Hypertension.1 While wide parts of the guidelines do not substantially differ from the previous 2018 European Society...
Author
Author
Preventive PCI or medical therapy alone for atherosclerotic coronary vulnerable plaques (PREVENT)
08 Apr 2024
Ali Nazmi Calik provides his take on the results of the PREVENT trial presented at ACC.24 in Atlanta.
Author
